Financial reports
20-F
2020 FY
Annual report (foreign)
4 Jun 21
NT 20-F
Notice of late annual filing (foreign)
30 Apr 21
20-F
2019 FY
Annual report (foreign)
31 Mar 20
10-Q
2019 Q3
Quarterly report
14 Nov 19
10-Q
2019 Q2
Quarterly report
14 Aug 19
10-Q
2019 Q1
Quarterly report
15 May 19
10-K
2018 FY
Annual report
1 Apr 19
10-Q
2018 Q3
Quarterly report
13 Nov 18
10-Q
2018 Q1
Quarterly report
13 Aug 18
Current reports
6-K
New Frontier Health Corporation Announces Completion of Going Private Transaction
26 Jan 22
6-K
Current report (foreign)
11 Jan 22
6-K
New Frontier Health Corporation Announces Shareholders’ Approval of Merger Agreement and Warrantholders’ Approval of Warrant Amendment
7 Jan 22
6-K
New Frontier Health Corporation Announces Extraordinary General Meeting of Shareholders and Solicitation for Warrantholder Consent
2 Dec 21
6-K
New Frontier Health Corporation Enters into Definitive Merger Agreement
4 Aug 21
6-K
New Frontier Health Corporation Receives NYSE Notice Regarding Late Form 20-F Filing
25 May 21
6-K
New Frontier Health Corporation Announces Fourth Quarter and Fiscal 2020 Financial Results
8 Apr 21
6-K
Current report (foreign)
31 Mar 21
6-K
New Frontier Health Corporation Announces Formation of Special Committee and Appointment of Advisors
18 Mar 21
6-K
New Frontier Health Corporation Announces Receipt of Preliminary Non-Binding “Going Private” Proposal
10 Feb 21
Registration and prospectus
15-12B
Securities registration termination
7 Feb 22
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Jan 22
POS AM
Prospectus update (post-effective amendment)
28 Jan 22
25-NSE
Exchange delisting
27 Jan 22
SC 13E3/A
Going private transaction (amended)
27 Jan 22
SC 13E3/A
Going private transaction (amended)
2 Dec 21
SC 13E3
Going private transaction
5 Oct 21
424B3
Prospectus supplement
18 Mar 21
424B3
Prospectus supplement
10 Feb 21
424B3
Prospectus supplement
2 Dec 20
Proxies
DEFA14A
Additional proxy soliciting materials
6 Dec 19
DEFA14A
Additional proxy soliciting materials
2 Dec 19
DEFM14A
Proxy related to merger
29 Nov 19
PRER14A
Preliminary revised proxy
22 Nov 19
PRER14A
Preliminary revised proxy
12 Nov 19
DEFA14A
Additional proxy soliciting materials
6 Nov 19
DEFA14A
Additional proxy soliciting materials
25 Oct 19
PRER14A
Preliminary revised proxy
25 Oct 19
PREM14A
Preliminary proxy related to merger
11 Sep 19
DEFA14A
Additional proxy soliciting materials
9 Sep 19
Other
EFFECT
Notice of effectiveness
31 Jan 22
SEC STAFF
SEC staff action: Order
19 Jan 22
EFFECT
Notice of effectiveness
9 Apr 20
EFFECT
Notice of effectiveness
29 Jan 20
CORRESP
Correspondence with SEC
28 Jan 20
UPLOAD
Letter from SEC
28 Jan 20
UPLOAD
Letter from SEC
25 Nov 19
CORRESP
Correspondence with SEC
22 Nov 19
UPLOAD
Letter from SEC
20 Nov 19
CORRESP
Correspondence with SEC
12 Nov 19
Ownership
SC 13G/A
Capital Research Global Investors
11 Feb 22
SC 13D/A
GOLDMAN SACHS GROUP INC
31 Jan 22
SC 13D/A
New Frontier Public Holding Ltd.
27 Jan 22
SC 13D/A
New Frontier Public Holding Ltd.
2 Dec 21
SC 13D/A
New Frontier Public Holding Ltd.
5 Oct 21
SC 13D
GOLDMAN SACHS GROUP INC
16 Aug 21
SC 13D/A
New Frontier Public Holding Ltd.
6 Aug 21
SC 13G/A
Capital Research Global Investors
16 Feb 21
SC 13D/A
New Frontier Public Holding Ltd.
16 Feb 21
SC 13G
Beneficial ownership report
14 Feb 20